Suppr超能文献

实验室中从卵巢切除标本回收的卵母细胞的体外成熟(IVM):一种有前景的“离体”卵母细胞冷冻保存方法,促成了欧洲首例持续妊娠报告。

In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

作者信息

Segers Ingrid, Mateizel Ileana, Van Moer Ellen, Smitz Johan, Tournaye Herman, Verheyen Greta, De Vos Michel

机构信息

Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium,

出版信息

J Assist Reprod Genet. 2015 Aug;32(8):1221-31. doi: 10.1007/s10815-015-0528-9. Epub 2015 Aug 8.

Abstract

PURPOSE

We present our center's experience with 34 consecutive cases who underwent in vitro maturation (IVM) of oocytes obtained from ovariectomy specimens and compare our data with updated literature data.

METHODS

Feasibility and efficiency of oocyte collection during ovarian tissue processing was assessed by the recovery rate, maturation rate, and embryological development after IVM.

RESULTS

On average, 14 immature oocytes were retrieved per patient during ovarian tissue processing in 33/34 patients. The overall maturation rate after IVM was 36%. The maturation rate correlated with the age of the patient and the duration of IVM. Predominately, oocyte vitrification was performed. Eight couples preferred embryo cryopreservation. Here, a 65% fertilization rate was obtained and at least one good-quality day 3 embryo was cryopreserved in 7/8 couples. The retrieval of oocytes ex vivo resulted in mature oocytes or embryos available for vitrification in 79% of patients. One patient with ovarian insufficiency following therapeutic embolization of the left uterine and the right ovarian artery because of an arteriovenous malformation had an embryo transfer of one good-quality warmed embryo generated after IVM ex vivo, which resulted in an ongoing clinical pregnancy.

CONCLUSIONS

IVM of oocytes obtained ex vivo during the processing of ovarian cortex prior to cryopreservation is a procedure with emerging promise for patients at risk for fertility loss, as illustrated by the reported pregnancy. However, more data are needed in order to estimate the overall success rate and safety of this novel approach.

摘要

目的

我们介绍了本中心连续34例从卵巢切除标本中获取卵母细胞进行体外成熟(IVM)的经验,并将我们的数据与最新的文献数据进行比较。

方法

通过IVM后的回收率、成熟率和胚胎发育情况评估卵巢组织处理过程中卵母细胞采集的可行性和效率。

结果

在34例患者中的33例卵巢组织处理过程中,平均每位患者回收14个未成熟卵母细胞。IVM后的总体成熟率为36%。成熟率与患者年龄和IVM持续时间相关。主要进行了卵母细胞玻璃化冷冻。8对夫妇选择胚胎冷冻保存。在此,获得了65%的受精率,8对夫妇中有7对至少冷冻保存了1个优质的第3天胚胎。体外获取卵母细胞使79%的患者获得了可用于玻璃化冷冻的成熟卵母细胞或胚胎。1例因动静脉畸形接受左子宫和右卵巢动脉治疗性栓塞后出现卵巢功能不全的患者,进行了体外IVM后产生的1个优质解冻胚胎的胚胎移植,结果获得了持续的临床妊娠。

结论

如所报道的妊娠情况所示,在冷冻保存前卵巢皮质处理过程中体外获取的卵母细胞进行IVM,对于有生育力丧失风险的患者是一种有前景的新方法。然而,需要更多数据来评估这种新方法的总体成功率和安全性。

相似文献

4
In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation.
J Assist Reprod Genet. 2018 Dec;35(12):2161-2171. doi: 10.1007/s10815-018-1317-z. Epub 2018 Sep 20.
5
Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes.
Fertil Steril. 2009 Jun;91(6):2391-8. doi: 10.1016/j.fertnstert.2008.04.014. Epub 2008 Jun 24.
7
IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
Reprod Biomed Online. 2012 Dec;25(6):603-7. doi: 10.1016/j.rbmo.2012.08.001. Epub 2012 Aug 31.
8
Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm.
Fertil Steril. 2012 Aug;98(2):503-7.e1-2. doi: 10.1016/j.fertnstert.2012.01.114. Epub 2012 Feb 23.

引用本文的文献

6
Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors.
Arch Gynecol Obstet. 2024 May;309(5):2143-2152. doi: 10.1007/s00404-024-07445-x. Epub 2024 Mar 17.
7
Pronuclear transfer rescues poor embryo development of -grown secondary mouse follicles.
Hum Reprod Open. 2024 Feb 10;2024(1):hoae009. doi: 10.1093/hropen/hoae009. eCollection 2024.
8
In Vitro Maturation, In Vitro Oogenesis, and Ovarian Longevity.
Reprod Sci. 2024 May;31(5):1234-1245. doi: 10.1007/s43032-023-01427-1. Epub 2023 Dec 30.
9
Factors associated with the collection of isolated immature oocytes during ovarian tissue cryopreservation.
J Assist Reprod Genet. 2023 Dec;40(12):2799-2807. doi: 10.1007/s10815-023-02948-z. Epub 2023 Oct 2.
10
The study of the efficiency of in vitro maturation of ovarian tissue oocytes in pediatric patients.
J Assist Reprod Genet. 2023 Dec;40(12):2787-2797. doi: 10.1007/s10815-023-02958-x. Epub 2023 Oct 2.

本文引用的文献

2
Fertility preservation for age-related fertility decline.
Lancet. 2015 Feb 7;385(9967):506-7. doi: 10.1016/S0140-6736(15)60198-2.
3
Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?
J Assist Reprod Genet. 2015 Apr;32(4):597-606. doi: 10.1007/s10815-015-0438-x. Epub 2015 Feb 4.
4
6
Fertility preservation in women with cancer.
Lancet. 2014 Oct 4;384(9950):1302-10. doi: 10.1016/S0140-6736(14)60834-5.
7
[In vitro oocyte maturation for female fertility preservation].
Gynecol Obstet Fertil. 2014 Sep;42(9):657-60. doi: 10.1016/j.gyobfe.2014.07.009. Epub 2014 Aug 19.
8
Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
Hum Reprod. 2014 Sep;29(9):1931-40. doi: 10.1093/humrep/deu158. Epub 2014 Jun 22.
9
Ovarian tissue cryopreservation: a committee opinion.
Fertil Steril. 2014 May;101(5):1237-43. doi: 10.1016/j.fertnstert.2014.02.052. Epub 2014 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验